<p>To evaluate for evidence of original antigenic sin, serum from mice in each group was tested for antibody against the A/Brisbane/10/07 H3 HA protein by ELISA assay at 24 days following x139 viral challenge. Data represent the average OD obtained at a given serum dilution from 5–6 individual mice per experimental group, with the exception of the sham-x139 group where only 2 mice were examined. There were no statistically significant differences between H3 antibody levels in the sham-immunized (X31-sham-x139) or HA-immunized (X31-HA-x139) mice when compared to antibody in the mice initially primed with the X31 virus and immunized with HA peptides without a subsequent H1 viral infection (X31-HA).</p
BackgroundVaccines against avian influenza viruses often require high hemagglutinin (HA) doses or ad...
<p>BALB/c mice (5 mice/group) were intravenously injected with 1×10<sup>7</sup> pfu of VSVs in 100 μ...
<p>Bars indicate the geometric mean titers±SEM of 6 mice in the H5N1 BPL-WIV vaccination group or th...
<p>Serum samples from the mice described in the legend to <a href="http://www.plosone.org/article/in...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>A–B: IgG serum antibodies specific to A/California/04/2009 (A) or A/PR8/34 (B) H1N1 influenza vir...
Aged (24–26 months) BALB/c mice were immunized twice with H1-VLP, split-virion vaccine or PBS. Three...
<p>Sera from 10 days post-last vaccination were used for the detection. (A) Detection of sera IgG an...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>Mice sequentially immunized (cohort III: cH9/1, cH6/1 and H1 soluble protein) are seroreactive to...
<p>BALB/c mice (n = 10) were vaccinated with f88M2e2-16, f88-ctr, human M2eHBc or PBS three times in...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>All mice were vaccinated once intramuscularly with dose of 0.5 µg HA H5N1 inactivated virus vacci...
<p>H5 HA-specific serum antibody response of mice elicited after i.m. immunization with 10<sup>7</su...
BackgroundVaccines against avian influenza viruses often require high hemagglutinin (HA) doses or ad...
<p>BALB/c mice (5 mice/group) were intravenously injected with 1×10<sup>7</sup> pfu of VSVs in 100 μ...
<p>Bars indicate the geometric mean titers±SEM of 6 mice in the H5N1 BPL-WIV vaccination group or th...
<p>Serum samples from the mice described in the legend to <a href="http://www.plosone.org/article/in...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>A–B: IgG serum antibodies specific to A/California/04/2009 (A) or A/PR8/34 (B) H1N1 influenza vir...
Aged (24–26 months) BALB/c mice were immunized twice with H1-VLP, split-virion vaccine or PBS. Three...
<p>Sera from 10 days post-last vaccination were used for the detection. (A) Detection of sera IgG an...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>Mice sequentially immunized (cohort III: cH9/1, cH6/1 and H1 soluble protein) are seroreactive to...
<p>BALB/c mice (n = 10) were vaccinated with f88M2e2-16, f88-ctr, human M2eHBc or PBS three times in...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>All mice were vaccinated once intramuscularly with dose of 0.5 µg HA H5N1 inactivated virus vacci...
<p>H5 HA-specific serum antibody response of mice elicited after i.m. immunization with 10<sup>7</su...
BackgroundVaccines against avian influenza viruses often require high hemagglutinin (HA) doses or ad...
<p>BALB/c mice (5 mice/group) were intravenously injected with 1×10<sup>7</sup> pfu of VSVs in 100 μ...
<p>Bars indicate the geometric mean titers±SEM of 6 mice in the H5N1 BPL-WIV vaccination group or th...